Upstream Bio: H.C. Wainwright cuts target price to $18 from $36
UPB•H.C. Wainwright cut its target price for Upstream Bio to $18 from $36.
Related News
Ceragon attends Craig-Hallum and Needham investor conferences
CRNT•
Europe gas prices rise on lower Norwegian flows
UNG•
Canada's Boyd Group Q3 sales up 28%, slightly missing estimates
BGSI•
Rigetti Computing: StoneX cuts target price to $20 from $25
RGTI•
Novo commits $200 million to the World Diabetes Foundation
NVO•